Duos Technologies looks set to expand sales on a new subscription model that broadens market and likely boosts gross margins. Read why I rate DUOT stock a buy.
Cautionary Notice Regarding Forward Looking Statements
The information contained in Item 7 contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as. | June 29, 2022
Operator
Good day, ladies and gentlemen and welcome to the Avid Bioservices Fourth Quarter Fiscal 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call may be recorded.
I would now like to hand the conference over to Tim Brons of Avid s Investor Relations Group. Please go ahead.
Tim Brons
Executive Vice President, Vida Strategic Partners, Inc.
Thank you. Good afternoon and thank you for joining us. On today s call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer. Today we will be providing an overview of Avid Bioservices contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended April 30th, 2021. After our prepared remarks, we will welcome your questions.